欧洲多中心研究:肺段切除与肺叶切除治疗外周早期肺腺癌的预后比较
经倾向性评分匹配后,两组5年无病生存、总生存及肺癌特异性生存相似,侵袭性病理亚型患者中肺段切除亦非独立危险因素,但局部区域复发线性风险数值较高。结论认为病理证实的早期肺腺癌侵袭性亚型患者行肺段切除后不应扩大切除至肺叶。
要点
- ≤2 cm外周早期肺腺癌中,肺段切除与肺叶切除的5年生存结局相似。
- 侵袭性病理亚型患者中,肺段切除并非无病生存、总生存或肺癌特异性生存的独立危险因素。
- 侵袭性亚型患者肺段切除后局部区域复发线性风险数值高于肺叶切除。
核心结论
- 对于病理证实的早期肺腺癌侵袭性亚型患者,行肺段切除后不应扩大切除至肺叶。
研究设计与样本
- 欧洲六中心回顾性多中心研究,纳入2015至2021年≤2 cm病理外周肺腺癌行肺叶或肺段切除的患者。
- 采用Cox回归分析总生存和无病生存,竞争回归分析肺癌特异性生存,调整患者和肿瘤相关因素。
主要发现
- 全部数据集和侵袭性亚型数据集中,肺叶与肺段切除的5年无病生存、总生存和肺癌特异性生存均相似。
- 侵袭性亚型患者中,5年无病生存肺叶87.3% vs 肺段86.6%(P=0.62),总生存86.4% vs 95.6%(P=0.61),肺癌特异性生存100% vs 95.6%(P=0.13)。
- 两个数据集中,肺段切除均非无病生存、总生存或肺癌特异性生存的独立危险因素。
- 侵袭性亚型患者中,局部区域复发线性风险肺叶8.21,肺段11.3,肺段切除者更高。
临床怎么用
- 对于≤2 cm外周早期肺腺癌,肺段切除可作为肺叶切除的替代选择,生存结局相似。
- 病理证实为侵袭性亚型的患者行肺段切除后,无需扩大切除至肺叶,但应关注局部区域复发风险。
局限性
- 回顾性多中心研究设计,存在选择偏倚可能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To analyse impact of segmentectomy on oncological outcomes of different peripheral early-stage lung adenocarcinoma patterns. METHODS: Retrospective multicentre study including patients who underwent either lobectomy or segmentectomy in 6 European centres from 2015 to 2021, for ≤2 cm pathological peripheral lung adenocarcinoma. Overall and disease-free survivals were assessed by cox-regression and lung cancer-specific survival by competing regression analyses to adjust for patient- and tumour-related factors both in the entire dataset and the in aggressive adenocarcinoma patterns dataset. RESULTS: Lobectomy and segmentectomy were performed in 481 (71%) and 193 (29%) patients, respectively. Propensity score matching was performed (n = 191). One hundred and 8 patients had a least an aggressive pattern. Five-year disease-free, overall and lung cancer-specific survivals were similar between patients who underwent lobectomy or segmentectomy in both entire and aggressive pattern datasets. In patients with aggressive pattern, 5-year disease-free (lobectomy 87.3%; segmentectomy 86.6%, P = 0.62), overall (lobectomy 86.4%; segmentectomy 95.6%, P = 0.61) and lung cancer-specific (lobectomy 100%; segmentectomy 95.6%, P = 0.13) survivals did not differ. Segmentectomy was not an independent risk factor for disease-free survival, neither for overall survival nor for lung cancer-specific survival in any of the 2 datasets. In patients with aggressive pattern, loco-regional recurrence (linearized risks: lobectomy 8.21; segmentectomy 11.3) was higher in patients who underwent segmentectomy. CONCLUSIONS: Resection should not be extended (to lobectomy) on patients who underwent segmentectomy for pathologically proven early-stage adenocarcinoma with aggressive patterns.
引用
- Lula LJ, Costa R, Rushwan A, et al. European multicentre study evaluating the prognosis of peripheral early-stage lung adenocarcinoma patients operated on by segmentectomy or lobectomy. Eur J Cardiothorac Surg. 2024. PMID: 39447052. doi:10.1093/ejcts/ezae388
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。